Interferon-beta induction/interferon-alpha2b plus ribavirin therapy in patients with chronic hepatitis C.
Kim KI, Sasase N, Taniguchi M, Mita K, Kinoshita K, Togitani T, Shikata M, Kimura N, Izawa S, Ohtani A, Nakao K, Muramoto Y, Kim SR, Nabeshima S, Ishii F, Tanaka K, Hayashi Y.
Kim KI, et al. Among authors: kim sr.
Int J Clin Pharmacol Res. 2005;25(2):71-6.
Int J Clin Pharmacol Res. 2005.
PMID: 16060397